Influence of oral contraceptives on coagulation tests in native blood and plasma. 1990

F Kunz, and C Pechlaner, and M Tabarelli, and E Sölder, and W D Zwierzina
Department of Internal Medicine, University of Innsbruck, Austria.

Routine coagulation laboratory tests, clotting times in native (not anticoagulated) whole blood, platelet-rich and platelet-poor plasma, and recalcification times in citrated whole blood, platelet-rich and platelet-poor plasma were performed in 14 healthy premenopausal women. Blood was taken before and after one or two cycles of low-dose oral contraceptives. After oral contraceptives a reduction in clotting time in native platelet-rich plasma and activated partial thromboplastin time were observed. Recalcification times in whole blood and platelet-rich plasma were shorter than clotting times in their native counterparts. The observed changes are compatible with a procoagulant effect seen soon after the start of oral contraceptive use. The absence of these changes in the recalcification times in citrate systems suggests a masking effect of citrate. The reduction in clotting times in native platelet-rich but not in platelet-poor plasma indicates that the hypercoagulability in oral contraceptives users is mainly related to platelets.

UI MeSH Term Description Entries
D010314 Partial Thromboplastin Time The time required for the appearance of FIBRIN strands following the mixing of PLASMA with phospholipid platelet substitute (e.g., crude cephalins, soybean phosphatides). It is a test of the intrinsic pathway (factors VIII, IX, XI, and XII) and the common pathway (fibrinogen, prothrombin, factors V and X) of BLOOD COAGULATION. It is used as a screening test and to monitor HEPARIN therapy. Activated Partial Thromboplastin Time,Cephalin-Kaolin Coagulation Time,Kaolin-Cephalin Coagulation Time,Thromboplastin Time, Partial,Coagulation Time, Cephalin-Kaolin,Cephalin Kaolin Coagulation Time,Coagulation Time, Cephalin Kaolin,Coagulation Time, Kaolin-Cephalin,Kaolin Cephalin Coagulation Time
D012016 Reference Values The range or frequency distribution of a measurement in a population (of organisms, organs or things) that has not been selected for the presence of disease or abnormality. Normal Range,Normal Values,Reference Ranges,Normal Ranges,Normal Value,Range, Normal,Range, Reference,Ranges, Normal,Ranges, Reference,Reference Range,Reference Value,Value, Normal,Value, Reference,Values, Normal,Values, Reference
D001777 Blood Coagulation The process of the interaction of BLOOD COAGULATION FACTORS that results in an insoluble FIBRIN clot. Blood Clotting,Coagulation, Blood,Blood Clottings,Clotting, Blood
D001780 Blood Coagulation Tests Laboratory tests for evaluating the individual's clotting mechanism. Coagulation Tests, Blood,Tests, Blood Coagulation,Blood Coagulation Test,Coagulation Test, Blood,Test, Blood Coagulation
D001792 Blood Platelets Non-nucleated disk-shaped cells formed in the megakaryocyte and found in the blood of all mammals. They are mainly involved in blood coagulation. Platelets,Thrombocytes,Blood Platelet,Platelet,Platelet, Blood,Platelets, Blood,Thrombocyte
D003278 Contraceptives, Oral, Hormonal Oral contraceptives which owe their effectiveness to hormonal preparations. Hormonal Oral Contraceptive,Hormonal Oral Contraceptive Agent,Contraceptive Agents, Estrogen,Contraceptive Agents, Oral, Hormonal,Hormonal Oral Contraceptive Agents,Oral Contraceptive Agents, Hormonal,Oral Contraceptives, Hormonal,Contraceptive, Hormonal Oral,Contraceptives, Hormonal Oral,Estrogen Contraceptive Agents,Hormonal Oral Contraceptives,Oral Contraceptive, Hormonal
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014914 Whole Blood Coagulation Time The time required by whole blood to produce a visible clot. Activated Coagulation Time, Whole Blood,Blood Coagulation Time, Whole,Coagulation Time, Whole Blood

Related Publications

F Kunz, and C Pechlaner, and M Tabarelli, and E Sölder, and W D Zwierzina
May 1987, Minerva ginecologica,
F Kunz, and C Pechlaner, and M Tabarelli, and E Sölder, and W D Zwierzina
August 1965, British medical journal,
F Kunz, and C Pechlaner, and M Tabarelli, and E Sölder, and W D Zwierzina
June 1986, The Journal of reproductive medicine,
F Kunz, and C Pechlaner, and M Tabarelli, and E Sölder, and W D Zwierzina
January 1971, Srpski arhiv za celokupno lekarstvo,
F Kunz, and C Pechlaner, and M Tabarelli, and E Sölder, and W D Zwierzina
July 1968, British medical journal,
F Kunz, and C Pechlaner, and M Tabarelli, and E Sölder, and W D Zwierzina
July 1985, Obstetrical & gynecological survey,
F Kunz, and C Pechlaner, and M Tabarelli, and E Sölder, and W D Zwierzina
January 2014, Deutsche medizinische Wochenschrift (1946),
F Kunz, and C Pechlaner, and M Tabarelli, and E Sölder, and W D Zwierzina
December 1968, Minerva ginecologica,
F Kunz, and C Pechlaner, and M Tabarelli, and E Sölder, and W D Zwierzina
March 1982, American journal of obstetrics and gynecology,
F Kunz, and C Pechlaner, and M Tabarelli, and E Sölder, and W D Zwierzina
March 1998, Contraception,
Copied contents to your clipboard!